NCT02325011 An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. Status COMPLETED Phase PHASE1
NCT02283281 Anesthetic Premedication With a Cannabis Extract (Cannapremed) Status RECRUITING Phase PHASE2/PHASE3
NCT02271347 An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease Status WITHDRAWN Phase PHASE2
NCT02269579 Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment Status WITHDRAWN Phase PHASE2
NCT02257684 A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) Status TERMINATED Phase PHASE2
NCT02238925 An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients Status COMPLETED Phase PHASE2
NCT02224703 GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome Status COMPLETED Phase PHASE3
NCT02224690 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Status COMPLETED Phase PHASE3
NCT02224560 Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Status COMPLETED Phase PHASE3
NCT02221869 A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy Status COMPLETED Phase PHASE3
NCT02150928 An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) Status WITHDRAWN Phase PHASE2
NCT02091375 Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) Status COMPLETED Phase PHASE3
NCT02091206 A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) Status COMPLETED Phase PHASE2
NCT02087306 Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Status COMPLETED Phase PHASE3
NCT02056782 A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT02053272 A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02038699 A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02006628 A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder Status COMPLETED Phase PHASE2